A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

American College of Cardiovascular Virtual Summit – Feb 17-19, 2022

Conference features three days of plenary sessions, mini-intensives, workshops and access to on-demand content

American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three days of live content on Feb. 17-19, 2022, providing opportunities for the entire CV team to learn from multi-dimensional education courses on CV management and leadership strategies.

Course director Bo Walpole, MD, FACC, and course co-directors Cathleen Biga, MSN, RN, FACC, and Geoffrey Rose, MD, FACC, have designed CV Summit for members of all practices—private, integrated and academic—to discover innovative approaches to patient care and clinician experience in the areas of: managing rapid change, transforming cardiovascular care, optimizing the clinician experience, navigating health care economics and enhancing the academic agenda. Participants will learn to employ leadership strategies that foster collaboration, teamwork, diversity and inclusivity, along with best practices to sustain workforce well-being, key elements of a value-based practice environment and much more.

Participants will also be able to join Biga and select faculty for a pre-conference workshop on Wednesday, Feb. 16, 6:30-8:00 p.m. ET to discuss “Building Your Foundation for the Cardiovascular Summit.”

Live Sessions Include:

  • How to Fix Healthcare
  • Planning for the Inevitable: Workforce and Patient Access Challenges
  • Culture Change: Professionalism, Anti-Bullying, and Harassment – What Do You Do at Your Institution to Approach These Challenges?
  • Health Care Systems, Employed Cardiovascular Physicians, and Independent Practices: Challenges and Opportunities

Posters

The following abstracts are a selection of the posters being presented. All ACC Cardiovascular Summit abstracts are embargoed until Monday, Feb. 14, 2022, at 9 a.m. ET.

  • Improving Blood Pressure Management Through Blood Pressure Recheck Compliance
  • Reducing Patient Blood Pressure Using the Hypertension Bootcamp Approach with Remote Patient Monitoring
  • Enhanced External Counterpulsation Improves Outcomes in Patients with Long COVID
  • Association Between Erectile Dysfunction, Cardiovascular Risk Factors and Coronary Artery Disease: Role of Exercise Stress Testing and International Index of Erectile Function Questionnaire
  • Improving Emergency Medical Services First Medical Contact to Primary Coronary Intervention Time
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy